Long‐Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer

Abstract

BackgroundRadiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of heart disease is uncertain. We performed a meta‐analysis to investigate the link between radiotherapy and long‐term cardiovascular morbidity and mortality in patients with breast cancer.Methods and ResultsWe performed a literature search using MEDLINE (January 1966 to January 2015) and EMBASE (January 1980 to January 2015) with no restrictions. Studies that reported relative risk (RR) estimates with 95%CIs for the associations of interest were included. Pooled effect estimates were obtained by using random‐effects meta‐analysis. Thirty‐nine studies involving 1 191 371 participants were identified. Patients who received left‐sided radiotherapy, as compared with those receiving right‐sided radiotherapy, experienced increased risks of developing coronary heart disease (RR 1.29, 95%CI 1.13‐1.48), cardiac death (RR 1.22, 95%CI 1.08‐1.37) and death from any cause (RR 1.05, 95%CI 1.01‐1.10). In a comparison of patients with radiotherapy and without radiotherapy, the RRs were 1.30 (95%CI 1.13‐1.49) for coronary heart disease and 1.38 (95%CI 1.18‐1.62) for cardiac mortality. Radiotherapy for breast cancer was associated with an absolute risk increase of 76.4 (95%CI 36.8‐130.5) cases of coronary heart disease and 125.5 (95%CI 98.8‐157.9) cases of cardiac death per 100 000 person‐years. The risk started to increase within the first decade for coronary heart disease and from the second decade for cardiac mortality.ConclusionsExposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent risk of coronary heart disease and cardiac mortality.

Calycosin Inhibits the Migration and Invasion of Human Breast Cancer Cells by Down-Regulation of Foxp3 Expression

“…Although new therapeutic strategies have significantly improved the survival rates of breast cancer patients, these have either limited effect on breast cancer patients with distant metastasis or none at all. Furthermore, many therapeutic strategies are accompanied by resistance and severe side effect, affecting the quality of patient’s life [3, 4]. Therefore, development of new therapeutic reagent for breast cancer will be of significance, especially one that can suppress tumor metastasis.…”

Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography

“…More specifically, this risk may be elevated for at least twenty years after irradiation and is related to the coexistence of other risk factors, such as circulatory and vascular disease. Moreover, a recent large meta-analysis including 39 studies with breast cancer survivors, revealed a higher risk of coronary disease and mortality during the first and second decade respectively, after radiation exposure (17). Nevertheless, the absolute risk seems to be too low to be able to offset the benefit of radiation.…”

Outcomes of cardiac surgery after mediastinal radiation therapy: A single‐center experience

“…9 Additionally, a recent meta-analysis including 1.2 million participants who underwent MRT as a treatment for breast cancer, indicated an increased risk of developing CAD and cardiac mortality (relative risk 1.30 and 1.38, respectively). 10 Previous studies have already shown worse outcomes of cardiac surgery in patients with a history of MRT compared to patients without a history of MRT. [11][12][13][14][15][16][17] These studies mostly researched a subset of cardiac procedures (mostly valvular surgery).…”

“…CAD was the most common complication, occurring in 19% of the cases 9 . Additionally, a recent meta‐analysis including 1.2 million participants who underwent MRT as a treatment for breast cancer, indicated an increased risk of developing CAD and cardiac mortality (relative risk 1.30 and 1.38, respectively) 10 …”